Arcutis Biotherapeutics Inc share price logo

Arcutis Biotherapeutics Inc Share Price

NASDAQ: ARQT

Small Cap

$24.99

+5.35

(+27.24%)

as on

Arcutis Biotherapeutics Inc Stock Performance

as on October 29, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $22
    $25.75
    downward going graph

    11.96%

    Downside

    3.04%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $8.21
    $21.84
    downward going graph

    67.15%

    Downside

    -12.61%

    Upside

    downward going graph

Arcutis Biotherapeutics Inc share price movements today

Previous Close
$19.64
Open
$22.50
Volume
13.7M
Day's Low - High
$22 - $25.75
52 Week Low - High
$8.21 - $21.84

Arcutis Biotherapeutics Inc Historical Returns

1 Month Return
+ 11.78 %
3 Month Return
+ 31.28 %
1 Year Return
+ 125.49 %
3 Year Return
+ 12.23 %
5 Year Return
-2.43 %

Arcutis Biotherapeutics Inc Stock Fundamentals & Key Indicators

Check Arcutis Biotherapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.4B

EPS (TTM)

-0.4483

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-6.47

Industry PE ratio

-0.8809294871794872

PEG Ratio

0

EBITDA

-80.1M

Revenue (TTM)

263.5M

Profit Margin

-35.40%

Return On Equity TTM

-57.33%

Arcutis Biotherapeutics Inc Stock Valuation

Track how Arcutis Biotherapeutics Inc P/E has moved over time to understand its valuation trends.

Arcutis Biotherapeutics Inc in the last 5 years

  • Overview

  • Trends

Lowest (-37.55x)

September 30, 2025

Today (-6.47x)

October 28, 2025

Industry (-0.88x)

October 28, 2025

Highest (-0.69x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -6.47x

Arcutis Biotherapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Arcutis Biotherapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$2.4B-2.43%-6.47-35.40%
BUY$60.7B283.23%-505.15-12.96%
NA$35.8BNANA-3.89%
BUY$108.0B101.68%29.9531.86%
BUY$61.3B3.22%14.5531.37%

Stock Returns calculator for Arcutis Biotherapeutics Inc Stock including INR - Dollar returns

The Arcutis Biotherapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Arcutis Biotherapeutics Inc investment value today

Current value as on today

₹2,92,043

Returns

₹1,92,043

(+192.04%)

Returns from Arcutis Biotherapeutics Inc Stock

₹1,86,912 (+186.91%)

Dollar Returns*

₹5,132 (+5.13%)

Analyst Recommendation on Arcutis Biotherapeutics Inc Stock

Based on 13 analysts

BUY

76.92%

Buy

23.08%

Hold

0.00%

Sell

Based on 13 analysts, 76.92% of analysts recommend a 'BUY' rating for Arcutis Biotherapeutics Inc. Average target price of $23.38

Arcutis Biotherapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Arcutis Biotherapeutics Inc.

What analysts predicted

-6.89%DOWNSIDE

Target Price

$23.38

Current Price

$24.99

Analyzed by

13 Analysts

Target

$23.38

Arcutis Biotherapeutics Inc target price $23.38, a slight downside of -6.89% compared to current price of $24.99. According to 13 analysts rating.

Arcutis Biotherapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Arcutis Biotherapeutics Inc Stock has increased by 219% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:219% versus previous 30 day period

Arcutis Biotherapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
2
5
38
13
49
30
44
71
65
81
Gross Profit
1
4
36
11
46
27
39
64
57
74
Operating Income
-76
-66
-36
-61
-31
-50
-39
-7
-24
-14
EBITDA
-72
-63
-33
-58
-27
-44
-33
-4
-18
-11
Interest Expense
7
7
7
7
7
7
6
5
2
3
Depreciation
0
0
0
0
0
0
1
0
3
0
Income Before Tax
-80
-70
-41
-66
-35
-52
-41
-10
-24
-15
Income Tax Expense
0
10
3
0
0
0
-
0
0
0
Net Income
-79
-70
-44
-66
-35
-52
-41
-10
-25
-15
Net Profit Margin
-2867.21%
-1367.84%
-117.47%
-490.05%
-71.38%
-169.59%
-92.81%
-15.12%
-38.06%
-19.49%

Arcutis Biotherapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
3
59
196
Gross Profit
-
-
0
0
0
2
54
177
Operating Income
-4
-19
-43
-136
-206
-301
-241
-128
EBITDA
-4
-19
-41
-135
-206
-294
-227
-109
Interest Expense
-
-
-
-
0
15
29
27
Depreciation
-
-
0
0
0
0
1
2
Income Before Tax
-4
-19
-41
-135
-206
-311
-259
-139
Income Tax Expense
-4
0
0
0
0
9
3
0
Net Income
-4
-19
-41
-135
-205
-311
-262
-140
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-8449.76%
-439.79%
-71.25%

Arcutis Biotherapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-70
-44
-66
-35
-52
-41
-10
-25
-15
Operating Cash Flow
-66
-43
-56
-31
-45
-34
0
-30
0
Investing Cash Flow
89
45
-62
-
-62
84
34
11
17
Financing Cash Flow
1
0
99
161
1
0
-97
0
1
Change in Cash
23
2
-19
101
-105
50
-63
-18
19

Arcutis Biotherapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-19
-41
-135
-206
-311
-262
-140
Operating Cash Flow
-14
-42
-113
-174
-257
-247
-112
Investing Cash Flow
-11
-26
-181
-75
-87
180
28
Financing Cash Flow
61
93
298
281
301
101
66
Change in Cash
35
23
3
31
-43
34
-17

Global Institutional Holdings in Arcutis Biotherapeutics Inc

Funds
Holdings
Suvretta Capital Management, LLC
9.62%
Jennison Associates LLC
9.27%
Rubric Capital Management LP
8.96%
BlackRock Inc
7.12%
Vanguard Group Inc
5.88%

Arcutis Biotherapeutics Inc News & Key Events

    Insights on Arcutis Biotherapeutics Inc

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Profit Spike

      img

      Netprofit is up for the last 2 quarters, -25.06M → -15.88M (in $), with an average increase of 57.8% per quarter

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 1 year, ARQT stock has moved up by 129.4%

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Revenue is up for the last 2 quarters, 65.84M → 81.50M (in $), with an average increase of 19.2% per quarter

    • imgPOSITIVE IMPACT

      Best in 1 Year

      img

      In the last 1 year, ARQT has outperformed top 5 stocks with highest market-cap in its industry

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 134.0% return, outperforming this stock by 121.8%

    About Arcutis Biotherapeutics Inc

    arcutis biotherapeutics, inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. its lead product candidate is arq-151, a topical cream formulation of roflumilast that is in phase iii clinical trials for the treatment of plaque psoriasis and atopic dermatitis. the company is also developing arq-154, a topical foam formulation of arq-151 for the treatment of seborrheic dermatitis and scalp psoriasis; arq-252, a selective topical small molecule inhibitor of janus kinase type 1 for hand eczema and other inflammatory dermatoses; and arq-255, a topical formulation of arq-252 designed to reach deeper into the skin to the postulated site of inflammation in alopecia areata. the company was formerly known as arcutis, inc. and changed its name to arcutis biotherapeutics, inc. in october 2019. arcutis biotherapeutics, inc. was founded in 2016 and is headquartered in westlake village, california.
    OrganisationArcutis Biotherapeutics Inc
    Headquarters3027 Townsgate Road, Westlake Village, CA, United States, 91361
    IndustryHealth Technology
    CEOMr. Todd Franklin Watanabe M.A.
    E-voting on sharesClick here to vote

    Key Management of Arcutis Biotherapeutics Inc

    Name

    Title

    Mr. Rajvir Madan

    Chief Digital & Technology Officer

    Mr. Steve Arias

    Vice President of Compliance & Privacy

    Mr. Kent Taylor

    Senior Vice President of Sales

    Mr. Todd Franklin Watanabe M.A.

    President, CEO & Director

    Dr. Bhaskar Chaudhuri Ph.D.

    Co-Founder & Independent Director

    Mr. Masaru Matsuda Esq., J.D.

    Senior VP, General Counsel & Corporate Secretary

    Mr. Larry Todd Edwards

    Executive VP & Chief Commercial Officer

    Dr. Patrick E. Burnett M.D., Ph.D.

    Executive VP & Chief Medical Officer

    Ms. Latha Vairavan

    Chief Financial Officer

    Ms. Amanda Sheldon

    Head of Corporate Communications

    FAQs

    What is Arcutis Biotherapeutics Inc share price today?

    Arcutis Biotherapeutics Inc share price today is $24.99 as on at the close of the market. Arcutis Biotherapeutics Inc share today touched a day high of $25.75 and a low of $22.

    What is the 52 week high and 52 week low for Arcutis Biotherapeutics Inc share?

    Arcutis Biotherapeutics Inc share touched a 52 week high of $21.84 on and a 52 week low of $8.21 on . Arcutis Biotherapeutics Inc stock price today i.e. is closed at $24.99,which is -14.42% down from its 52 week high and 204.38% up from its 52 week low.

    What is Arcutis Biotherapeutics Inc's market capitalisation today?

    Arcutis Biotherapeutics Inc market capitalisation is $0.00T as on .

    How to invest in Arcutis Biotherapeutics Inc Stock (ARQT) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Arcutis Biotherapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Arcutis Biotherapeutics Inc Shares that will get you 0.0600 shares as per Arcutis Biotherapeutics Inc share price of $24.99 per share as on October 29, 2025 at 1:29 am IST.

    What is the minimum amount required to buy Arcutis Biotherapeutics Inc Stock (ARQT) from India?

    Indian investors can start investing in Arcutis Biotherapeutics Inc (ARQT) shares with as little as ₹88.237 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹882.37 in Arcutis Biotherapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Arcutis Biotherapeutics Inc share’s latest price of $24.99 as on October 29, 2025 at 1:29 am IST, you will get 0.4002 shares of Arcutis Biotherapeutics Inc. Learn more about fractional shares .

    What are the returns that Arcutis Biotherapeutics Inc has given to Indian investors in the last 5 years?

    Arcutis Biotherapeutics Inc stock has given -2.43% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?